內地最大碳纖維基地正式投產
據《澎湃新聞》報道,中國建材萬噸碳纖維生產線在西寧正式投產,這是內地最大的碳纖維生產基地。
該項目總投資50億元人民幣,突破了超大容量聚合、乾噴濕紡紡絲等核心技術工藝,建成了國內首條具有自主知識產權的千噸級乾噴濕紡碳纖維產業化生產線,並首次實現單線年產3,000噸高性能碳纖維生產線設計和高端成套技術自主可控。這種高端碳纖維可耐超過2,000攝氏度高溫,重量僅為鋼鐵的四分之一,強度卻是鋼鐵的十倍,可廣泛應用於國產大飛機等航空航天、交通運輸、新能源等領域。
中國建材萬噸碳纖維生產基地的投產,將有效緩解供應緊張,加快打造內地碳纖維原創技術「策源地」和現代產業鏈「鏈長」。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.